Yuhan Corporation
000100
Rang în acțiuni
#3832
Yuhan Corporation, a prominent South Korean pharmaceutical firm established in... Yuhan Corporation, a prominent South Korean pharmaceutical firm established in 1926 and headquartered in Seoul, specializes in the research, development, and manufacture of active pharmaceutical ingredients (APIs) and intermediates for both domestic and international markets. Its extensive product portfolio encompasses a wide array of prescription pharmaceuticals (ETC), addressing therapeutic areas such as cardiovascular, alimentary, genito-urinary, metabolic, respiratory, allergy, and neurological systems, alongside anti-infectives, anti-cancer treatments, and hormonal therapies. Notable offerings include Revanex, an acid pump antagonist designed for treating peptic ulcers and gastritis-related mucosal injury. Beyond prescription drugs, Yuhan Corporation provides a diverse range of over-the-counter (OTC) medications, including vitamins, mineral supplements, hepatopathy treatments, tonics, and drugs for respiratory, alimentary, dermatological, and pain relief applications. The company also extends its reach into consumer health and household goods, producing items like bleaches, detergents, pesticides, and oral care products. Further diversifying its operations, Yuhan is involved in the dental sector, supplying implants, equipment, consumables, and dental care solutions, and manufactures veterinary medical supplies for livestock, aquatic species, and companion animals. Additionally, it offers contract manufacturing services to other businesses.
Preț acțiune
$63.22
Capitalizare de piață
$4.27B
Schimbare (1 zi)
-3.12%
Schimbare (1 an)
-23.57%
Țară
KR
Tranzacționează Yuhan Corporation (000100)
Categorie
Healthcare
Raport P/B pentru Yuhan Corporation (000100)
Raport P/B la data de October 2026 TTM: 3.01
Conform celor mai recente rapoarte financiare și prețului acțiunilor Yuhan Corporation, raportul P/B actual (TTM) este 3.01. La sfârșitul anului 2024, compania avea un P/B de 4.26.
Istoricul raportului P/B pentru Yuhan Corporation din 2007 până în 2026
Raport P/B la sfârșitul fiecărui an
| An | Raport P/B | Schimbă |
|---|---|---|
| 2026 (TTM) | 3.01 | -23.89% |
| 2025 | 3.95 | -7.28% |
| 2024 | 4.26 | 66.37% |
| 2023 | 2.56 | 24.28% |
| 2022 | 2.06 | -6.66% |
| 2021 | 2.21 | -17.25% |
| 2020 | 2.67 | 56.39% |
| 2019 | 1.71 | 23.87% |
| 2018 | 1.38 | -0.40% |
| 2017 | 1.38 | 6.44% |
| 2016 | 1.30 | -33.49% |
| 2015 | 1.96 | 49.31% |
| 2014 | 1.31 | -13.72% |
| 2013 | 1.52 | 4.85% |
| 2012 | 1.45 | 25.35% |
| 2011 | 1.15 | -32.24% |
| 2010 | 1.70 | -8.86% |
| 2009 | 1.87 | -22.38% |
| 2008 | 2.41 | -0.50% |
| 2007 | 2.42 | 0.00% |
Raport P/B pentru companii similare sau competitoare
| Companie | Raport P/B | Diferență raport P/B | Țara |
|---|---|---|---|
| 1.9834 | -34.03% |
DE
|
|
| 2.1139 | -29.69% |
DE
|
|
| 1.3124 | -56.35% |
JP
|
|
| 6.3468 | 111.10% |
CH
|
|
| 5.0287 | 67.26% |
IN
|
